FDA 483 - Medisca, Inc. - November 20, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Medisca, Inc. in Plattsburgh, NY, a drug substance repacker/relabeler, revealed seven significant observations. These findings primarily concern inadequate calibration and cleaning procedures for hazardous drug repackaging equipment, inappropriate personnel gowning, and failures in preventing contamination during material handling. Additionally, the firm lacked proper component testing for excipients, failed to validate and document container closure integrity, and maintained production environments with contamination risks.
ID · cdf0c117-ea4a-4cca-a5cd-b9c25614f129